Max Kates, MD
Urology · Baltimore, MDNPI 1487910600
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $123,860 of the $139,006 with a category attached, or 89.1%. 15 manufacturers reported payments, led by Urogen Pharma, Inc. at 58.1% of the total. 2025 is the largest year on record at $76,970, more than ten times the $3,922 reported in 2019. Among urology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $1829.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogen Pharma, Inc.$81K
- Photocure Inc$14K
- Pfizer$10K
- Merck$8K
- Astellas Pharma Global Development$6K
- Seagen Inc.$5K
- plus $16K from 9 others
Across 81 payments — averaging $10,628 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urogen Pharma, Inc.$302K
- Seagen Inc.$271K
- Photocure Inc$115K
- Pfizer$103K
- Ferring Pharmaceuticals AS$56K
- Janssen Research & Development, LLC$15K
What the payments were for
- Consulting fees$123,86089%
- Speaking & faculty fees$9,4007%
- Travel & lodging$3,7223%
- Food & beverage$1,9631%
- Education$610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogen Pharma, Inc. | 24 | $80,702 |
| Photocure Inc | 6 | $13,875 |
| Pfizer | 5 | $9,687 |
| Merck | 9 | $7,864 |
| Astellas Pharma Global Development | 3 | $5,900 |
| Seagen Inc. | 3 | $4,550 |
| Janssen Global Services, LLC | 2 | $4,150 |
| Intuitive Surgical | 12 | $4,007 |
| AstraZeneca | 2 | $2,540 |
| Immunitybio, Inc. | 1 | $2,400 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,950 |
| Olympus Winter & Ibe GmbH | 1 | $1,080 |
| Olympus America Inc. | 3 | $169 |
| Johnson & Johnson | 3 | $114 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PADCEV$18,490
- Cysview$13,875
- Da Vinci Surgical System$3,701
- IMFINZI$2,505
- ANKTIVA$2,400
- Single Use Repositionable Clip$1,080
How this compares
$139,006 in reported general payments places this provider in the 95th percentile of 274 urology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 26 | $509 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 23 | $335 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $309 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $47 |
Paid to pharmacies, not to this prescriber.
Other urology in Baltimore
- Benjamin LowentrittBaltimore$549K
- Amin HeratiBaltimore$160K
- Arthur BurnettBaltimore$132K
- Aaron WeinbergBaltimore$106K
- Brian MatlagaBaltimore$99K
- Ronald TutroneBaltimore$89K
- Jared WinokerBaltimore$62K
- Jason LevyBaltimore$55K
- Arvin GeorgeBaltimore$46K
- Christian PavlovichBaltimore$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.